San Francisco: October 20, 2021 -- Today the Healthcare Technology Report picked Darmiyan CEO Padideh Kamali-Zare in its coveted list: Top 25 Women Leaders in Biotechnology of 2021.
Darmiyan, best known for its AI-Powered BrainSee technology that earned an FDA Breakthrough Designation in May, also was a 2021 finalist in UCSF’s Health Awards. Using standard, non-invasive clinical brain MRI, BrainSee can objectively measure brain health, including detecting Alzheimer’s disease at the early prodromal stage, enabling timely medical interventions and care planning. Early detection or rule-out of Alzheimer’s disease non-invasively (no injection or radiation) and affordably is nonexistent in the clinical market today.
Investigators from Stanford, HMRI, Washington University, Baycrest, UHN, Hamilton HHS and elsewhere in the US and Canada involved in BrainSee’s validation believe the software platform will fill a gap in the clinical field by extracting from MRIs insights, maps and grades of brain tissue health.
Editors wrote: "As we have seen in recent years and months, biotechnology plays a critical role in the well-being of our global society. With the COVID-19 pandemic shining a spotlight on the importance of life sciences, both private and public organizations are providing unprecedented levels of funding and support to companies in biotech space.
The accomplished women selected for this year's awards have distinguished themselves through their professional achievements and contributions to their organizations. "
Winner of the World Technology Award in the field of Biotechnology and an Adjunct Professor at Stanford Medical School Dr. Ahmad Salehi noted, "Padideh Kamali-Zare has developed into a visionary and supportive leader of a biotech company, Darmiyan, that is looking to change the landscape of Alzheimer's disease." Salehi, who is a Darmiyan scientific advisor added, "For diagnosis we are too dependent on subjective tests such as neuropsychology-based cognitive tests and invasive biomarker tests. The possibility to have BrainSee, a single brain modality that advises and informs the clinician about cognitive impairment, would be of great benefit to patients and their caregivers and likely senior living."
"Dr. Kamali-Zare has epitomized and embraced the culture of health innovation," longevity market guru Mary Furlong observed. "She and her team have developed a new, innovative and needed technology to predict the trajectory of age-related neurodegenerative disorders and enable both clinicians and neuroscience researchers to measure brain health."
Today Healthcare Tech Report placed Dr. Kamali-Zare among those "building new companies, women unlocking revolutionary ways to treat deadly diseases, and other top female executives who are helping their companies navigate market expansion, legal considerations, and brand awareness, among other areas." They selected for the list exceptional leaders based on hundreds of nominations and comprehensive analysis of professional milestones achieved, longevity in the biotech field and demonstrated domain expertise. Further research was conducted using a broad set of data including feedback from colleagues, industry influence, key company events milestones, previous honors and recognition, and numerous other metrics.
Darmiyan applauds the achievements of all the Top 25 Women Leaders in Biotechnology of 2021 who are listed here.
